LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH SEQUENTIAL TREATMENT OF BRAF MUTANT ADVANCED MELANOMA PATIENTS

被引：0
|
作者：
Tarhini, Ahmad [1 ]
McDermott, David [2 ,3 ]
Ambavane, Apoorva [4 ]
Benedict, Agnes [4 ]
Lee, Cho-Han [5 ]
Ritchings, Corey [5 ]
Stwalley, Brian [5 ]
Regan, Meredith [2 ,6 ]
Atkins, Michael [7 ]
机构：
[1] Moffitt Comprehens Canc Ctr & Res Inst, Tampa, FL USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Evidera, London, England
[5] Bristol Myers Squibb, Princeton, NJ USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219
引用
收藏
页码：A130 / A131
页数：2
相关论文
共 50 条
  • [41] Ruthenium Eye Plaques for Uveal Melanoma: Long-Term Clinical Outcomes
    Marwaha, G.
    Medina, C.
    Naik, M.
    Ward, M. C.
    Wilkinson, D.
    Singh, A. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S303 - S303
  • [42] Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Grob, Jean-Jacques
    Rutkowski, Piotr
    Lao, Christopher D.
    Cowey, C. Lance
    Schadendorf, Dirk
    Wagstaff, John
    Dummer, Reinhard
    Ferrucci, Pier Francesco
    Smylie, Michael
    Butler, Marcus O.
    Hill, Andrew
    Marquez-Rodas, Ivan
    Haanen, John B. A. G.
    Guidoboni, Massimo
    Maio, Michele
    Schoffski, Patrick
    Carlino, Matteo S.
    Lebbe, Celeste
    McArthur, Grant
    Ascierto, Paolo A.
    Daniels, Gregory A.
    Long, Georgina, V
    Bas, Tuba
    Ritchings, Corey
    Larkin, James
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 127 - +
  • [43] Long-Term Outcomes of Advanced Melanoma Patients Resected to No Evidence of Disease Following Immune Checkpoint Blockade
    Sreeram, Aravind
    Bartlett, Edmund K.
    Ariyan, Charlotte E.
    Bello, Danielle M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S449 - S449
  • [44] OUTCOMES FOLLOWING CESSATION OF BRAF ± MEK INHIBITION AFTER ACHIEVING COMPLETE RESPONSE IN BRAF MUTANT ADVANCED MELANOMA
    Girgis, C.
    Vanella, V.
    Menzies, A. M.
    Guminski, A.
    Kefford, R. F.
    Long, G. V.
    Ascierto, P.
    Carlino, M. S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 41 - 41
  • [45] Clinical Outcomes of Combined BRAF and MEK Inhibition With Stereotactic Radiation for BRAF Mutant Melanoma Brain Metastases
    Echevarria, M.
    Ahmed, K. A.
    Patel, B.
    Abuodeh, Y. A.
    Naghavi, A. O.
    Sarangkasiri, S.
    Johnstone, P. A. S.
    Etame, A. B.
    Yu, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E115 - E116
  • [46] Long-term and sequential treatment for osteoporosis
    Foessl, Ines
    Dimai, Hans P.
    Obermayer-Pietsch, Barbara
    NATURE REVIEWS ENDOCRINOLOGY, 2023, 19 (09) : 520 - 533
  • [47] Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis
    Yoon, Hee-Young
    Kim, Ho Jeong
    Song, Jin Woo
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [48] Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis
    Hee-Young Yoon
    Ho Jeong Kim
    Jin Woo Song
    Respiratory Research, 23
  • [49] Long-term clinical outcomes of patients with sympathetic ophthalmia
    Mavris, Neofytos
    Amer, Radgonde
    INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [50] Long-term and sequential treatment for osteoporosis
    Ines Foessl
    Hans P. Dimai
    Barbara Obermayer-Pietsch
    Nature Reviews Endocrinology, 2023, 19 : 520 - 533
12345